NCT06612788
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- West Virginia University: Rockefeller Neuroscience Institute Morgantown, West Virginia, United States
Clinical trial condition
Opioid-Related Disorders
Explore clinical trials studying Opioid-Related Disorders. Study availability and eligibility vary by location and protocol.
1,203 public trials
195 recruiting studies
Opioid-Related Disorders trial results
NCT04559893
- Conditions
- Addiction, Behavior, Behavior, Addictive, +14 more
- Locations
-
- Hubert Humphrey Comprehensive Health Center Los Angeles, California, United States
- Providence Saint John's Health Center Santa Monica, California, United States
- First Choice Community Healthcare - South Broadway Medical Center Albuquerque, New Mexico, United States
- First Choice Community Healthcare - South Valley Medical/Dental Center Albuquerque, New Mexico, United States
Completed
The Life STORRIED Study
NCT03134092
- Conditions
- Behavior, Chemically-Induced Disorders, Communication, +9 more
- Locations
-
- University of Alabama- Birmingham Birmingham, Alabama, United States
- Mayo Clinic Rochester, Minnesota, United States
- Northwell Health Manhasset, New York, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT05547542
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- New Haven, Connecticut New Haven, Connecticut, United States
- Yale PET Center New Haven, Connecticut, United States
NCT04433975
- Conditions
- Chemically-Induced Disorders, Chronic Pain, Medication Assisted Treatment, +9 more
- Locations
-
- Veterans Affair Ann Arbor Healthcare System Ann Arbor, Michigan, United States
- Michigan Medicine Ann Arbor, Michigan, United States
NCT05116852
- Conditions
- Bereavement, Chemically-Induced Disorders, Drug Misuse, +9 more
- Locations
-
- Cambridge Health Alliance Cambridge, Massachusetts, United States
NCT05053503
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
- Locations
-
- Hazelden Betty Ford Foundation Rancho Mirage, California, United States
- Gaudenzia, Inc. Crownsville, Maryland, United States
- Hazelden Betty Ford Foundation Center City, Minnesota, United States
- Hazelden Betty Ford Foundation Plymouth, Minnesota, United States
NCT05221866
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +6 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
Completed
OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
NCT04948307
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Parkway Medical Center Birmingham, Alabama, United States
- North County Clinical Research Oceanside, California, United States
- Artemis Institute for Clinical Research San Diego, California, United States
- Wetlin Research Associates, Inc San Diego, California, United States
NCT06087991
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- University of Utah Salt Lake City, Utah, United States